Chloramphenicol is a broad-spectrum antibiotic that was once among the most widely prescribed drugs in the world but fell sharply out of favor because of a rare, sometimes fatal blood disorder it can trigger. It remains in clinical use today for specific infections where alternatives are limited, and it is still a go-to treatment for bacterial eye infections in many countries. Its story is one of remarkable effectiveness weighed against serious risk, and understanding both sides matters whether you encounter it as a prescription, an over-the-counter eye drop, or a name on an old medicine label.
How Chloramphenicol Works
Chloramphenicol kills or slows bacteria by interfering with their ability to build proteins. It binds to the peptidyl transferase center of the bacterial ribosome, the molecular machine bacteria use to assemble proteins, and blocks the formation of new protein chains.1PubMed Central. Binding and Action of Amino Acid Analogs of Chloramphenicol upon the Bacterial Ribosome Without proteins, bacteria cannot grow, reproduce, or maintain their cell structures. Because this target site is shared across a wide range of bacteria, chloramphenicol works against both gram-positive and gram-negative organisms, which is why it earned the label “broad-spectrum.” The drug also has an unusual physical property that shapes many of its clinical uses: it is highly fat-soluble, meaning it crosses biological barriers that stop many other antibiotics.
Where Chloramphenicol Is Still Used
In wealthier countries, chloramphenicol has been largely replaced by newer antibiotics for most infections. But it retains a handful of roles where its unique properties give it an edge, or where no good alternative exists.
Eye Infections
Chloramphenicol eye drops and ointment remain one of the most common treatments for bacterial conjunctivitis worldwide. In the United Kingdom and several other countries, chloramphenicol eye drops are available without a prescription. The drug penetrates eye tissues well, and the very small amount absorbed from topical application keeps systemic side effects to a minimum. That said, even topical eye use has been linked, in rare cases, to serious blood-related side effects, a point covered below.
Meningitis and Central Nervous System Infections
Chloramphenicol’s fat solubility lets it cross the blood-brain barrier far more effectively than many antibiotics. In studies of children with bacterial meningitis, chloramphenicol reached the cerebrospinal fluid at about 32% of its blood concentration, roughly double the penetration of ampicillin and four times that of penicillin G.2PubMed. Fosfomycin penetration into the cerebrospinal fluid of patients with bacterial meningitis For this reason it was long considered the drug of choice for Haemophilus influenzae meningitis in children.3PubMed. Chloramphenicol levels in cerebrospinal fluid in meningitis Today, third-generation cephalosporins have largely taken over that role in settings where they are available, but chloramphenicol remains important in resource-limited hospitals.
Typhoid Fever
Chloramphenicol was the original breakthrough treatment for typhoid fever and is still used against it in parts of the world. However, growing resistance among Salmonella typhi strains and the availability of more effective alternatives have weakened its position. Comparative studies in children have found that ceftriaxone produces faster bacterial clearance than chloramphenicol, even though chloramphenicol still reduces symptoms effectively.4PubMed Central. Comparative Effectiveness Study of Chloramphenicol and Ceftriaxone in the Treatment of Typhoid Fever in Children Admitted to Putri Hijau Kesdam I/Bb Hospital Medan
Rickettsial Infections
For tick-borne diseases like Rocky Mountain spotted fever, doxycycline is the standard treatment. Chloramphenicol is considered a backup for patients who cannot take doxycycline, such as pregnant women, although this swap comes with a trade-off: treatment with chloramphenicol has been linked to a higher percentage of fatal outcomes compared with tetracycline-class drugs for rickettsial infections.5JAMA Internal Medicine. Rocky Mountain Spotted Fever: A Clinician’s Dilemma The reason is not entirely clear, but it means chloramphenicol is reserved for situations where the first-line option truly cannot be used.
Common Side Effects
The most frequently encountered side effect of chloramphenicol taken by mouth or by injection is bone marrow suppression. This form is dose-dependent, meaning it becomes more likely at higher doses and with longer courses. It shows up as lower red blood cell production and sometimes lower white blood cell or platelet counts. The mechanism is damage to mitochondria, the energy-producing structures inside cells; red blood cell precursors seem particularly vulnerable because of the way their internal amino acid pools interact with the drug.6PubMed. Chloramphenicol toxicity: 25 years of research The good news is that this type of marrow suppression reverses once the drug is stopped. Doctors monitor blood counts during treatment specifically to catch it early.
Gastrointestinal symptoms like nausea, vomiting, and diarrhea are also common. These are usually manageable and resolve with dose adjustment or supportive care.
A less well-known side effect is optic neuropathy. Patients on prolonged courses, particularly those with cystic fibrosis who may receive the drug repeatedly, have developed vision problems including loss of visual sharpness, difficulty distinguishing red from green, and changes visible on eye examination.7JAMA Ophthalmology. Chloramphenicol Optic Neuropathy This is another reason long-term use is discouraged when alternatives exist.
The Two Serious Warnings
Beyond the common, reversible side effects, chloramphenicol carries two rare but potentially devastating risks that define its reputation.
Aplastic Anemia
The more feared of the two is aplastic anemia, a condition in which the bone marrow essentially stops producing blood cells. Unlike the dose-dependent marrow suppression described above, aplastic anemia from chloramphenicol is idiosyncratic: it is not related to how much drug you take or for how long.8PubMed. Fatal aplastic anemia following topical administration of ophthalmic chloramphenicol It strikes unpredictably and can occur even after a single course of treatment. The condition is often fatal without aggressive intervention like a bone marrow transplant. Estimates of the risk vary widely, but the consensus puts it somewhere in the range of one in every 20,000 to 40,000 patients treated. What makes it especially alarming is that it has been reported even after topical use. Case reports document fatal aplastic anemia following nothing more than chloramphenicol eye drops.9PubMed. Fatal aplastic anemia following topical administration of ophthalmic chloramphenicol These cases are exceedingly rare, but they help explain why some countries restrict or avoid chloramphenicol eye drops while others sell them over the counter.
Gray Baby Syndrome
Newborns, especially premature infants, process chloramphenicol very differently from older children and adults. Their livers have not yet developed the full capacity to break down the drug through a process called glucuronidation, so the drug accumulates to toxic levels in the blood.10PubMed Central. Chloramphenicol-induced gray baby syndrome: case report and review of current literature The result is gray baby syndrome: the infant’s skin turns an ashy gray color, the abdomen becomes distended, blood pressure drops, and without prompt treatment the outcome can be fatal. This syndrome was recognized in the late 1950s after a cluster of infant deaths, and it is the reason chloramphenicol is now used in newborns only as an absolute last resort, with careful dose adjustment and blood-level monitoring.
How Your Body Handles Chloramphenicol
Most of a chloramphenicol dose is processed by the liver, which converts the active drug into inactive products. The primary route is conjugation with glucuronic acid. Only about 5 to 15% of the drug leaves the body unchanged through the kidneys.11PubMed. Clinical pharmacokinetics of chloramphenicol and chloramphenicol succinate This heavy dependence on liver metabolism is the root of several practical concerns. People with liver disease or liver injury clear the drug more slowly, raising the risk of toxicity. Animal research has shown that even trauma unrelated to the liver can reduce chloramphenicol clearance by roughly a quarter.12PubMed. Effects of model traumatic injury on hepatic drug metabolism in the rat. IV. Glucuronidation And as noted above, newborns’ immature liver enzyme systems are the direct cause of gray baby syndrome.
Drug Interactions Worth Knowing About
Because chloramphenicol is metabolized in the liver, it competes with other drugs that use the same enzyme pathways. Laboratory studies have shown that chloramphenicol is a potent inhibitor of two key liver enzymes, CYP2C19 and CYP3A4.13PubMed Central. Chloramphenicol is a potent inhibitor of cytochrome P450 isoforms CYP2C19 and CYP3A4 in human liver microsomes These enzymes are responsible for breaking down a long list of commonly used medications, so chloramphenicol can cause those drugs to build up in your system to higher-than-expected levels. The practical consequences include:
- Warfarin: Chloramphenicol slows warfarin metabolism, which can push anticoagulant effects dangerously high and increase bleeding risk.
- Phenytoin: Blood levels of this seizure medication can rise, leading to toxicity symptoms like dizziness and involuntary eye movements.
- Oral hypoglycemics: Some diabetes drugs processed by the same enzymes can accumulate and cause dangerously low blood sugar.
- Immunosuppressants: Drugs like tacrolimus and cyclosporine, also cleared by CYP3A4, can reach toxic levels if given alongside chloramphenicol.
Anyone prescribed chloramphenicol alongside other medications should expect their doctor to review these interactions and possibly adjust doses or monitor blood levels more closely.
How Bacteria Become Resistant
Chloramphenicol resistance has been spreading for decades, and bacteria have evolved several distinct strategies to defeat the drug. The most common is enzymatic inactivation: bacteria produce an enzyme called chloramphenicol acetyltransferase, which attaches a chemical group to the drug molecule. This modified version of chloramphenicol can no longer bind to the ribosome, so the bacteria survive.14PubMed Central. Resistance to fusidic acid in Escherichia coli mediated by the type I variant of chloramphenicol acetyltransferase The gene for this enzyme often sits on plasmids, small circular pieces of DNA that bacteria swap among themselves, which means resistance can spread rapidly between species.15PubMed Central. The structural basis for substrate versatility of chloramphenicol acetyltransferase CATI
A second strategy is efflux: bacteria pump the drug out of the cell before it can reach the ribosome. The cmlA gene, identified in several gram-negative organisms, encodes just such a pump.16PubMed Central. Characterization of chloramphenicol and florfenicol resistance in Escherichia coli associated with bovine diarrhea A related gene called flo confers resistance not only to chloramphenicol but also to florfenicol, a veterinary analog, which is one way resistance jumps between animal and human medicine.
A third mechanism is particularly worrying. The Cfr methyltransferase chemically modifies the ribosome itself so that chloramphenicol can no longer attach. The trouble is that this single modification simultaneously blocks several other antibiotic classes, including lincosamides, oxazolidinones, pleuromutilins, and streptogramin A drugs.17PubMed Central. The Cfr rRNA methyltransferase confers resistance to Phenicols, Lincosamides, Oxazolidinones, Pleuromutilins, and Streptogramin A antibiotics One gene, five classes of antibiotics rendered useless. This kind of cross-resistance is a genuine concern for infectious-disease specialists because it narrows treatment options for some of the hardest-to-treat hospital infections.18PubMed. The cfr and cfr-like multiple resistance genes
Chloramphenicol in Veterinary Medicine
Chloramphenicol has a complicated status in animal health. In the United States, the European Union, and many other jurisdictions, it is banned from use in food-producing animals because of the aplastic anemia risk to people who might consume drug residues in meat, milk, or eggs. The ban is essentially zero-tolerance: regulators do not accept any detectable level of chloramphenicol in food products.
In companion animals like cats and dogs, however, chloramphenicol still serves as a valuable last-resort antibiotic. A recent retrospective study of cats with complicated, multidrug-resistant infections found that nine out of twelve cats achieved either bacterial clearance or clinical cure after treatment with oral chloramphenicol, and side effects were limited to mild gastrointestinal upset in two animals.19PubMed Central. Retrospective description of the clinical use of chloramphenicol in client-owned cats: 12 cases (2015–2023) The targeted bacteria included methicillin-resistant Staphylococcus species and multidrug-resistant Enterococcus faecium, organisms for which oral alternatives are scarce. Pet owners should be aware that handling chloramphenicol tablets carries a small theoretical risk: the drug can be absorbed through the skin, and people with a genetic susceptibility to aplastic anemia could be affected. Wearing gloves when administering the drug to pets is standard advice.
Chloramphenicol Residues in Food
Despite the bans on use in food animals in many countries, chloramphenicol residues still show up in food-safety testing, particularly in regions where enforcement is patchy. A large surveillance study in Guangzhou, China, detected chloramphenicol in about 17% of more than 1,400 food samples tested, with the highest average concentrations found in mollusks.20PubMed Central. Probabilistic Risk Assessment of Dietary Exposure to Chloramphenicol in Guangzhou, China Pond fish, pork, and poultry contributed the most to overall dietary exposure. The actual health risk from these trace residues is debated. Aplastic anemia is an idiosyncratic reaction, which means any exposure, no matter how small, theoretically carries some risk because the reaction is not dose-dependent. This is precisely why regulators set a zero-tolerance policy rather than a “safe” threshold: with an unpredictable reaction, there is no dose that can be guaranteed safe for every person.
Where Chloramphenicol Stands Today
A systematic review and meta-analysis of randomized controlled trials concluded that chloramphenicol cannot be recommended as a first-line treatment for respiratory tract infections, meningitis, or typhoid fever because alternatives are probably more effective.21PubMed. Efficacy and safety of chloramphenicol: joining the revival of old antibiotics? Systematic review and meta-analysis of randomized controlled trials That assessment captures the drug’s modern position well. It is not the best option for most infections anymore, and it carries risks that newer antibiotics do not. But it is far from obsolete. In resource-limited settings where newer drugs are unavailable or unaffordable, chloramphenicol remains a critical tool. In specialty situations like multidrug-resistant infections with no oral alternatives, it fills a gap nothing else can. And in ophthalmic use, millions of people worldwide use it safely every year for bacterial eye infections.
The broader context matters too. As antibiotic resistance steadily shrinks the pool of effective drugs, older antibiotics that fell out of fashion are getting a second look. Chloramphenicol is part of that conversation. Its mechanism is well understood, its spectrum is broad, its tissue penetration is excellent, and its cost is low. The challenge is the same one clinicians faced in the 1960s: balancing those strengths against the small but real chance of a catastrophic immune reaction. For the foreseeable future, chloramphenicol will likely remain exactly what it has been for decades: a drug of genuine value, used cautiously, in the right patients, at the right time.